Central nervous system pharmacokinetics of psychiatric drugs.
Salazar
D E
DE
Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey, USA.
Fischman
A J
AJ
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000378:metabolism; D000928:Antidepressive Agents / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics*; D002490:Central Nervous System / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D010879:Piperazines / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics*; D011388:Prolactin / Q000378:metabolism; D011699:Putamen / Q000737:chemistry*; D011743:Pyrimidines / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics*; D017367:Selective Serotonin Reuptake Inhibitors / Q000493:pharmacokinetics
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000928:Antidepressive Agents; D006854:Hydrocortisone; D010879:Piperazines; D011388:Prolactin; D011743:Pyrimidines; D017367:Selective Serotonin Reuptake Inhibitors; C101699:BMS 181101